Mexico’s Leap into Pharmacogenomics
In a bustling hospital ward in Mexico City, Dr. Laura Hernández wrestles with a critical yet common issue—adverse drug reactions (ADRs). These medical events are the hidden adversary of international healthcare systems, responsible for approximately 7% of hospital admissions globally. But what if there was a way to anticipate these reactions before they occur? Enter […]
Read more →